Press Release
– FRESCO Phase III trial results for fruquintinib in colorectal cancer in an oral presentation –
– Five abstracts in total accepted for fruquintinib, savolitinib and sulfatinib –
London: Thursday, May 18, 2017: Hutchison Chin
Read More